Fairmount Funds Management LLC - Director at Dianthus Therapeutics, Inc. /DE/

Insider Transactions and Holdings

Entity Type
Company
Role
Director
Stock Symbol
DNTH on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Fairmount Funds Management LLC - trading volume in the past year for Dianthus Therapeutics, Inc. /DE/

Holdings reported by Fairmount Funds Management LLC for Dianthus Therapeutics, Inc. /DE/

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 2,700,691 $32.4 M $12.00 Apr 1, 2024 By Fairmount Healthcare Fund II LP
Pre-Funded Warrants (Right to Buy) 832,333 $9.99 M $12.00 Jan 22, 2024 Indirect Common Stock
Common Stock 62,146 $746 K $12.00 Apr 1, 2024 By Fairmount SPV III, LLC
Common Stock 0 $0 $12.00 Apr 1, 2024 By Fairmount Healthcare Fund LP
Stock Option (Right to Buy) 11,000 May 23, 2024 Indirect Common Stock

Transactions reported by Fairmount Funds Management LLC for Dianthus Therapeutics, Inc. /DE/

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership